301 related articles for article (PubMed ID: 32737696)
1. ASO Author Reflections: Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer: Is It Oncologically Safe?
Piltin MA; Boughey JC
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):707-708. PubMed ID: 32737696
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Sentinel Lymph Node Removal After Neoadjuvant Chemotherapy in Clinically Node-Negative Patients Can Stop After Removal of Three Lymph Nodes.
Murphy BL; Boughey JC
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):848-849. PubMed ID: 32696307
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Low Rates of Axillary Recurrence in Clinically Node-Positive Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy Alone Following Pathologic Response to Neoadjuvant Chemotherapy.
Wong SM; Boileau JF
Ann Surg Oncol; 2021 May; 28(5):2630-2631. PubMed ID: 33123855
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Positive Sentinel Lymph Node in Breast Cancer Surgery.
Millen EC; Cavalcante FP
Ann Surg Oncol; 2022 Feb; 29(2):1096-1097. PubMed ID: 34561776
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: A Perspective on Nonsentinel Axillary Lymph Node Status in Sentinel Lymph Node-Positive Early Breast Cancer After Primary Systemic Therapy and ALND-Predict.
Cebrecos I; Mension E; Vidal M; Schettini F
Ann Surg Oncol; 2023 Sep; 30(9):5705-5706. PubMed ID: 36820935
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: Avoiding an Axillary Lymph Node Dissection: The Benefit of Neoadjuvant Chemotherapy for Occult Primary Breast Cancer.
Botty van den Bruele A; Plitas G; Pilewskie M
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):865-866. PubMed ID: 32725524
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Refining Risk Assessment in Node-Positive Breast Cancer Patients Eligible for Sentinel Lymph Node Biopsy Alone.
Mamtani A; Morrow M
Ann Surg Oncol; 2020 Oct; 27(10):3593-3594. PubMed ID: 32440719
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: MicroRNA-Based Nomogram for Prediction of Sentinel Lymph Node Metastasis in ER+/HER2- Breast Cancer in Hoping for a Possible Omission of Sentinel Lymph Node Biopsy.
Okuno J; Miyake T; Shimazu K; Noguchi S
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):810-811. PubMed ID: 32632881
[No Abstract] [Full Text] [Related]
9. [Sentinel lymph node biopsy and neoadjuvant treatment in breast cancer].
Duraes M; Guillot E; Seror J; Pouget N; Rouzier R
Bull Cancer; 2017 Oct; 104(10):892-901. PubMed ID: 28890124
[TBL] [Abstract][Full Text] [Related]
10. ASO Author Reflections: Standardizing Pathology Examination of Sentinel Lymph Nodes in Invasive Lobular Carcinoma: Less Is More.
Hieken TJ; Solanki MH
Ann Surg Oncol; 2022 Oct; 29(10):6466-6467. PubMed ID: 35930110
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Omission of Axillary Lymph Node Dissection for Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant Chemotherapy: Not Ready for Primetime?
Almahariq MF; Chen PY; Dekhne N; Dilworth JT
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):869-870. PubMed ID: 32737699
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Fluorescence-Guided Sentinel Node Biopsy for Breast Cancer.
Kedrzycki MS; Elson DS; Leff DR
Ann Surg Oncol; 2021 Jul; 28(7):3749-3750. PubMed ID: 33185734
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy.
Verreck E; van Steenhoven J; van Dalen T
Ann Surg Oncol; 2023 Sep; 30(9):5633-5634. PubMed ID: 37378845
[No Abstract] [Full Text] [Related]
14. Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer.
Gatek J; Petru V; Kosac P; Ratajsky M; Duben J; Dudesek B; Jancik P; Zabojnikova M; Katrusak J; Opelova P; Podrazska L; Vazan P; Kudlova P; Holik P; Melichar B; Vrana D
Neoplasma; 2020 Nov; 67(6):1329-1334. PubMed ID: 32749847
[TBL] [Abstract][Full Text] [Related]
15. Excision of both pretreatment marked positive nodes and sentinel nodes improves axillary staging after neoadjuvant systemic therapy in breast cancer.
Simons JM; van Pelt MLMA; Marinelli AWKS; Straver ME; Zeillemaker AM; Pereira Arias-Bouda LM; van Nijnatten TJA; Koppert LB; Hunt KK; Smidt ML; Luiten EJT; van der Pol CC
Br J Surg; 2019 Nov; 106(12):1632-1639. PubMed ID: 31593294
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting the number of sentinel lymph nodes removed in patients having surgery for breast cancer.
Dixon JM; Grewar J; Twelves D; Graham A; Martinez-Perez C; Turnbull A
Breast Cancer Res Treat; 2020 Nov; 184(2):335-343. PubMed ID: 32809181
[TBL] [Abstract][Full Text] [Related]
17. Is Regression after Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer Different in Sentinel and Non-sentinel Nodes?
Cserni G; Zombori T; Andreu X; Bianchi S; Regitnig P; Amendoeira I; Balmativola D; Kovács A; Cordoba A; Reiner A; Kulka J; Kaya H; Liepniece-Karele I; Quinn C; Kővári B
Pathol Oncol Res; 2018 Jan; 24(1):167-170. PubMed ID: 28391512
[TBL] [Abstract][Full Text] [Related]
18. ASO Author Reflections: Value of Sentinel Node Biopsy for Chest Wall Recurrence After Mastectomy.
Vicini E; Fontana SKR; Leonardi MC; Veronesi P; Galimberti V
Ann Surg Oncol; 2022 Mar; 29(3):1761-1762. PubMed ID: 34757548
[No Abstract] [Full Text] [Related]
19. [The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
Péley G; Török K; Farkas E; Mátrai Z; Horváth Z; Sinkovics I; Hitre E; Rényi-Vámos F; Orosz Z; Köves I
Magy Onkol; 2006; 50(1):19-23. PubMed ID: 16617379
[TBL] [Abstract][Full Text] [Related]
20. Sentinel Node Lymph Node Surgery After Neoadjuvant Therapy: Principles and Techniques.
Racz JM; Caudle AS
Ann Surg Oncol; 2019 Oct; 26(10):3040-3045. PubMed ID: 31342394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
